Search research articles
Contact Us
Filters
Showing results (211-220 of 222) with videos related to
Page
of 23
Sort By:
Cancer Causes & Control : CCC
|
May 8, 2014
Gene-environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American men
Christine Neslund-Dudas, Albert M Levin, Jennifer L Beebe-Dimmer, et al.
European Journal of Medicinal Chemistry
|
June 16, 2018
In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer
Valentina Gambini, Martina Tilio, Eunice Wairimu Maina, et al.
Oncotarget
|
January 14, 2017
Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases
Chong Zhao, Xin Chen, Changshan Yang, et al.
Cell Research
|
September 1, 2010
Physiological levels of ATP negatively regulate proteasome function
Hongbiao Huang, Xiaoyan Zhang, Shujue Li, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)
|
May 19, 2018
Association between cadmium and androgen receptor protein expression differs in prostate tumors of African American and European American men
Christine M Neslund-Dudas, Russell B McBride, Ashoka Kandegedara, et al.
Scientific Reports
|
June 11, 2014
A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases
Ningning Liu, Chunjiao Liu, Xiaofen Li, et al.
Nature
|
December 7, 2017
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Zdenek Skrott, Martin Mistrik, Klaus Kaae Andersen, et al.
Cell Reports
|
December 25, 2012
Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo
Xiaofen Li, Shouting Liu, Hongbiao Huang, et al.
Oncotarget
|
April 19, 2013
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care
Richard E Kast, John A Boockvar, Ansgar Brüning, et al.
Nature Reviews. Cancer
|
November 12, 2021
Connecting copper and cancer: from transition metal signalling to metalloplasia
Eva J Ge, Ashley I Bush, Angela Casini, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 222) with videos related to
Sort By:
Page
of 23
Cancer Causes & Control : CCC
|
May 8, 2014
Gene-environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American men
Christine Neslund-Dudas, Albert M Levin, Jennifer L Beebe-Dimmer, et al.
European Journal of Medicinal Chemistry
|
June 16, 2018
In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer
Valentina Gambini, Martina Tilio, Eunice Wairimu Maina, et al.
Oncotarget
|
January 14, 2017
Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases
Chong Zhao, Xin Chen, Changshan Yang, et al.
Cell Research
|
September 1, 2010
Physiological levels of ATP negatively regulate proteasome function
Hongbiao Huang, Xiaoyan Zhang, Shujue Li, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)
|
May 19, 2018
Association between cadmium and androgen receptor protein expression differs in prostate tumors of African American and European American men
Christine M Neslund-Dudas, Russell B McBride, Ashoka Kandegedara, et al.
Scientific Reports
|
June 11, 2014
A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases
Ningning Liu, Chunjiao Liu, Xiaofen Li, et al.
Nature
|
December 7, 2017
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Zdenek Skrott, Martin Mistrik, Klaus Kaae Andersen, et al.
Cell Reports
|
December 25, 2012
Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo
Xiaofen Li, Shouting Liu, Hongbiao Huang, et al.
Oncotarget
|
April 19, 2013
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care
Richard E Kast, John A Boockvar, Ansgar Brüning, et al.
Nature Reviews. Cancer
|
November 12, 2021
Connecting copper and cancer: from transition metal signalling to metalloplasia
Eva J Ge, Ashley I Bush, Angela Casini, et al.
Page
of 23